In pediatric oncology, cachexia is characterized by which of the following?

Prepare for the ASPEN Certified Nutrition Support Clinician (CNSC) Exam. Study with structured quizzes and detailed insights to enhance your knowledge and readiness. Get set for success!

Multiple Choice

In pediatric oncology, cachexia is characterized by which of the following?

Explanation:
Cachexia is a catabolic state driven by cancer and inflammation that leads to progressive loss of both lean body mass (muscle) and adipose tissue. It reflects ongoing tissue wasting from metabolic changes, not just simple weight loss from reduced intake. This combination of muscle and fat loss distinguishes cachexia from other forms of weight change. The option describing gradual weight loss alone doesn’t capture the active loss of lean tissue and fat that characterizes cachexia, and the idea of maintaining lean mass with fat loss would imply a different pattern of wasting. Decreased energy expenditure is not typical of cachexia, which often involves increased metabolic rate driven by inflammatory mediators.

Cachexia is a catabolic state driven by cancer and inflammation that leads to progressive loss of both lean body mass (muscle) and adipose tissue. It reflects ongoing tissue wasting from metabolic changes, not just simple weight loss from reduced intake. This combination of muscle and fat loss distinguishes cachexia from other forms of weight change.

The option describing gradual weight loss alone doesn’t capture the active loss of lean tissue and fat that characterizes cachexia, and the idea of maintaining lean mass with fat loss would imply a different pattern of wasting. Decreased energy expenditure is not typical of cachexia, which often involves increased metabolic rate driven by inflammatory mediators.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy